✨ Free AI Report
Hyperfine, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Hyperfine, Inc.
Company Research

Hyperfine, Inc.: Business Overview, Financials & Competitive Analysis

Hyperfine is a health technology company producing and commercializing the Swoop Portable MR Imaging System, which generates MRI images at lower magnetic field strength than conventional MRI scanners. Recent clinical ...

Analyst-debate audio for Hyperfine, Inc.

AskCyborg analysts argue the bull and bear cases for Hyperfine, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
5/ 10Mixed

Cyborg Score thesis

High-risk medical device innovator with transformative portable MRI technology facing execution and commercialization challenges...

Read the full analyst-debate transcript →
Industry Medical Devices & Healthcare Equipment Manufacturing
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Hyperfine, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Hyperfine, Inc. Overview

Pro stress-test →

Hyperfine is a health technology company producing and commercializing the Swoop Portable MR Imaging System, which generates MRI images at lower magnetic field strength than conventional MRI scanners. Recent clinical validation through the NEURO PMR study showed the portable Swoop MRI achieved 92% diagnostic concordance with standard MRI and demonstrated superior patient experience in outpatient neurology clinics.

Strategic Profile

Pro stress-test →

The company is positioned for rapid clinical adoption and global expansion, with the Swoop system expected to achieve outsized revenue growth, strong recurring high-margin revenue, and substantial operating margin improvements. Hyperfine recently obtained regulatory approval from India's Central Drugs Standard Control Organization in December 2025 and is planning commercial launches in India and other international markets.

Competitive Landscape

Pro stress-test →

Hyperfine competes in the medical imaging market, targeting displacement of traditional fixed MRI systems with its portable ultra-low-field alternative that offers accessibility and cost advantages. Primary competition comes from incumbent MRI manufacturers (GE Healthcare, Siemens, Philips) with established installed bases and conventional high-field systems, plus emerging portable/point-of-care imaging competitors.

Industry Context

Hyperfine, Inc. operates in Medical Devices & Healthcare Equipment Manufacturing.

Key facts

Founded: 2014 · Headquarters: Guilford, Connecticut, US · Employees: 111 · Revenue: $0.01B · Market cap: $0.11B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Hyperfine, Inc..

  • NEURO PMR study validated Swoop's clinical viability with 92% diagnostic concordance to standard MRI and 4x higher patient preference across comfort and anxiety metrics
  • Jefferson Abington Hospital study demonstrated $590 average cost savings per patient and 18-hour reduction in MRI wait times, establishing economic value proposition
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • December 2025FDA clearance for Optive AI multi-direction DWI imaging software for improved stroke detection
  • December 2025India regulatory approval from CDSCO; partnership with Radiosurgery Global for commercial launch
  • +2 moreTrack every material event for Hyperfine, Inc. as it happens. Explore monitoring →
Get alerted when Hyperfine, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

MRI SystemsConventional high-field MRI systems with established clinical infrastructure→MRI SystemsFull-spectrum clinical imaging including traditional MRI platforms→Portable Imaging SystemsPortable ultrasound and point-of-care imaging alternative→

Compare Hyperfine, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Hyperfine, Inc. operates in Medical Devices & Healthcare Equipment Manufacturing. See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Healthcare Equipment Manufacturing research →
NEW · MCP server

Ask your AI assistant about Hyperfine, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Hyperfine, Inc. and its top competitor on Cyborg Score”
“What did Hyperfine, Inc. do this quarter?”
“Is Hyperfine, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Hyperfine, Inc. do?+
Hyperfine is a health technology company producing and commercializing the Swoop Portable MR Imaging System, which generates MRI images at lower magnetic field strength than conventional MRI scanners. Recent clinical ...
What is Hyperfine, Inc.'s Cyborg Score?+
Hyperfine, Inc. has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Hyperfine, Inc.'s main competitors?+
Named competitors include MRI Systems, MRI Systems, Portable Imaging Systems. The full competitive landscape is in the AskCyborg report.
How can I get the full Hyperfine, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Hyperfine, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Hyperfine, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.